CII
WST icon

CR Intrinsic Investors’s West Pharmaceutical WST Stock Holding History

CR Intrinsic Investors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-250,000
Closed -$8.78M – 407
2013
Q2 		$8.78M Buy
+250,000
New +$8.23M 0.3% 130

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

CR Intrinsic Investors's WST Position: Q3 2013 in Review

CR Intrinsic Investors sold out of West Pharmaceutical (WST) in Q3 2013, closing a stake of 250,000 shares — an estimated $8.78M sold.

CR Intrinsic Investors first reported a position in WST in Q2 2013 and held it in 1 quarter. The position peaked at $8.78M in Q2 2013. 205 funds tracked by Wall St. Rank hold WST as of Q3 2013.

  • CR Intrinsic Investors reported no remaining West Pharmaceutical position as of Q3 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 250,000 West Pharmaceutical shares in Q3 2013, an estimated $8.78M.
  • CR Intrinsic Investors first reported a position in West Pharmaceutical in Q2 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's West Pharmaceutical position peaked at $8.78M in Q2 2013.
  • 205 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2013.

Based on CR Intrinsic Investors's 13F filing for Q3 2013, filed 14 Nov 2013.